Research
What a compounding pharmacy has to report to a state
California puts several different clocks on a sterile compounder, and they are not the same clock. Ten days for what another regulator did, twelve hours for a recall, and a separate set of numbers entirely for an outsourcing facility.
Ten days: what another regulator did
A licence establishes that a regulator may look. Reporting duties decide what the regulator learns without looking, and how quickly. California builds those duties directly into the sterile compounding licence sections rather than leaving them to regulation, writing them as continuing obligations rather than as conditions of application.
The obligations are aimed at events that would otherwise stay inside the business: a decision by another regulator, the loss of an accreditation, a recall, an adverse effect, a complaint. Each is something a pharmacy learns first and a board learns second, and the clock is the state's answer to how long second is allowed to take.
The longest of the California clocks covers regulatory history, and it runs from the action rather than from any discovery.
An in-state sterile compounding pharmacy must provide to the board a copy of any disciplinary or other action taken by another state within ten days of the action. The phrase is "disciplinary or other action", which is broader than a formal discipline order.
The same section requires the pharmacy to notify the board within ten days of the suspension of any accreditation held by the pharmacy. Accreditation is voluntary; losing it is reportable in California all the same.
The nonresident version widens the first duty by one word that matters. A nonresident sterile compounding licensee must provide a copy of any disciplinary or other action taken by its state of residence or another state, within ten days.
For an out-of-state pharmacy, that means its home regulator's action is reportable to California on the same ten-day clock as any other state's. California does not wait to hear about it through the ordinary licensure cycle.
Twelve hours: recalls and adverse effects
The short clocks in the California pharmacy sections attach to events with a product in circulation.
An in-state sterile compounding pharmacy must provide to the board, within twelve hours, any recall notice issued by the pharmacy for sterile drug products it has compounded.
The adverse-effect duty is written in the same section and is broader than a confirmed causal finding. Adverse effects reported or potentially attributable to a pharmacy's sterile drug product shall be reported to the board within twelve hours and immediately reported to the MedWatch programme of the federal Food and Drug Administration.
"Reported or potentially attributable" is the operative phrase. The duty is triggered by a report and by potential attribution, not by an investigation concluding that the product caused anything.
The nonresident section carries the identical twelve-hour pair, with the recall duty scoped to sterile drug products the pharmacy has compounded that have been shipped into, or dispensed in, California. A recall of a product that never reached the state is outside that particular sentence.
The extra duty on a pharmacy that ships in
California gives its nonresident sterile compounding licensees one obligation the in-state section does not contain.
A nonresident sterile compounding pharmacy shall advise the board of any complaint it receives from a provider, pharmacy, or patient in California.
There is no threshold in that sentence. It is not limited to clinical complaints, to written complaints, or to complaints the pharmacy considers well founded.
The reason for the asymmetry is visible in the rest of the section. California inspects its own sterile compounders directly and inspects nonresident ones at least once annually at the licensee's expense, but the day-to-day signal from an out-of-state facility is thinner, and complaints are how a distant regulator hears that something changed.
Virginia builds a related expectation into nonresident registration from a different direction, requiring a nonresident pharmacy to maintain a continuous quality improvement programme as required of resident pharmacies. The mechanism differs; the intent is the same one, which is to stop the distance from lowering the standard.
An outsourcing facility runs on different numbers
The California outsourcing facility licence carries its own reporting list, and the clocks in it are not the pharmacy clocks. Reading one set onto the other produces confident, wrong statements.
An outsourcing facility must provide the board with a copy of any disciplinary or other action taken by another state or the federal drug agency within ten days of the action. That one matches, and it adds the federal regulator to the list of sources.
The recall clock is longer than the pharmacy one: notice within twenty-four hours of any recall notice issued by the outsourcing facility, with no shipped-into-California limitation in that clause.
The adverse-effect clock is also twenty-four hours, running from a different starting point again: notice within twenty-four hours after learning of adverse effects reported or potentially attributable to the outsourcing facility's products.
Complaints get the longest clock and the narrowest scope. The facility must provide a copy of any clinically related complaint it receives involving its compounded products, from or involving any provider, pharmacy, or patient in California, within seventy-two hours of receipt. Three different licences, four different intervals, and a reader who assumes uniformity gets all of them wrong.
One duty that runs inside the building
California adds a reporting duty that starts with a person rather than with a document, and it sits in the pharmacist-in-charge section rather than the compounding article.
The pharmacist-in-charge or pharmacist on duty must immediately notify store management or the building owner or a similar entity of any conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, and management must take immediate and reasonable steps to address and resolve them.
The escalation is time-boxed. If the conditions are not resolved within twenty-four hours, the pharmacist-in-charge or pharmacist on duty must ensure the board is timely notified.
The statute lists examples that are recognisably about a physical room, including workplace safety and health hazards presenting an immediate risk, sustained temperatures that could affect ambient drug stability according to manufacturer data on acceptable storage conditions, and vermin infestation that poses a risk to the safety or efficacy of medicine.
The section also protects the channel itself, stating that nothing in that subdivision limits or restrains a pharmacist-in-charge, pharmacy technician, or member of the public from communicating with the board, including filing a complaint. Where the board's executive officer then has a reasonable belief that such conditions exist, the section provides for a cease and desist order affecting the operations at issue, which remains in effect until the conditions are abated or for no more than thirty days, whichever is earlier.
Key takeaways
- California writes continuing reporting duties into the sterile compounding licence itself, not only into regulation.
- Another state's disciplinary or other action is reportable within ten days, as is suspension of an accreditation.
- A sterile compounding pharmacy reports a recall and an adverse effect to the board within twelve hours.
- The adverse-effect duty is triggered by a report or potential attribution, not by proven causation.
- A nonresident sterile compounder must advise the California board of any complaint from a California provider, pharmacy or patient.
- A California outsourcing facility runs on twenty-four-hour recall and adverse-effect clocks and a seventy-two-hour complaint clock.
Frequently asked questions
How fast does a California sterile compounder have to report a recall?
Within twelve hours for a pharmacy. The in-state section requires the pharmacy to provide the board, within twelve hours, any recall notice it issued for sterile drug products it has compounded. The nonresident section carries the same twelve-hour duty, scoped to products that have been shipped into or dispensed in California. A California-licensed outsourcing facility is on a different clock: notice within twenty-four hours of any recall notice it issues.
Does a report of an adverse effect have to be proven before it is reportable?
No. The California sterile compounding sections say adverse effects reported or potentially attributable to the pharmacy's sterile drug product shall be reported to the board within twelve hours and immediately reported to the MedWatch programme of the federal drug agency. The trigger is a report or potential attribution, not a finding of causation. The outsourcing facility section uses the same "reported or potentially attributable" language on a twenty-four-hour clock running from learning of them.
Is losing an accreditation reportable in California?
Yes, for sterile compounding licensees. Both the in-state and nonresident sections require the pharmacy to notify the board within ten days of the suspension of any accreditation held by the pharmacy. Accreditation is voluntary, but its suspension is a reportable event on the same ten-day clock the statute uses for another state's disciplinary or other action.
Does an out-of-state compounder have to tell California about complaints?
The nonresident sterile compounding section requires the pharmacy to advise the board of any complaint it receives from a provider, pharmacy, or patient in California. There is no threshold written into that sentence, and the in-state section contains no equivalent clause. A California-licensed outsourcing facility has a narrower but still specific duty: a copy of any clinically related complaint involving its compounded products from or involving a California provider, pharmacy or patient, within seventy-two hours of receipt.
Are the clocks the same across the different California licences?
They are not, which is why they are worth reading individually. Ten days covers another regulator's action across all three licence types. Recalls are twelve hours for a sterile compounding pharmacy and twenty-four for an outsourcing facility. Adverse effects are twelve hours for a pharmacy and twenty-four for an outsourcing facility. Complaints are immediate in wording for a nonresident pharmacy and seventy-two hours for an outsourcing facility.
Is there a duty about the condition of the room itself?
California places one on the pharmacist-in-charge or pharmacist on duty, who must immediately notify store management of conditions presenting an immediate risk of death, illness, or irreparable harm, and must ensure the board is timely notified if those conditions are not resolved within twenty-four hours. The statute names sustained temperatures that could affect drug stability and vermin infestation among the examples, and preserves the right of a pharmacist, technician or member of the public to contact the board directly.
Sources
Each document below is named as it names itself, with the date printed on that document rather than the day it was read.
- California Business and Professions Code section 4127.1, sterile compounding pharmacy licence, including the ten-day and twelve-hour reporting duties — California Legislative Information, California Legislature, January 2014
- California Business and Professions Code section 4127.2, nonresident sterile compounding licence, including the duty to advise the board of California complaints — California Legislative Information, California Legislature, January 2014
- California Business and Professions Code section 4129.1, outsourcing facility licence, including the twenty-four-hour and seventy-two-hour reporting duties — California Legislative Information, California Legislature, January 2017
- California Business and Professions Code section 4113, pharmacist-in-charge, including the immediate-risk escalation duty and the cease and desist provision — California Legislative Information, California Legislature, January 2026
- Code of Virginia section 54.1-3434.1, Nonresident pharmacies to register with Board, including the continuous quality improvement requirement — Virginia Law, Virginia General Assembly, 2016